Codeine Sulfate Oral Solution
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Codeine Sulfate Oral Solution contains NLT 93.0% and NMT 105.0% of the labeled amount of codeine sulfate [(C18H21NO3)·H2SO4].
2 IDENTIFICATION
2.1 A. The retention time of the codeine peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
2.2 B. Thin-Layer Chromatography
Diluent: Methanol and water (25:75)
Standard solution: 1 mg/mL of USP Codeine Sulfate RS in Diluent
Sample solution: 1 mg/mL of codeine sulfate in Diluent
Chromatographic system
- Mode: TLC
- Adsorbent: 0.25-mm layer of chromatographic silica gel mixture
- Application volume: 10 µL
- Developing solvent system: Methanol, ethyl acetate, water, and ammonium hydroxide (135:85:1:0.5)
Analysis
Samples: Standard solution and Sample solution
Develop the plate until the solvent front has moved about three-fourths of the length of the plate, mark the front, and allow to evaporate. Place the plate in an iodine chamber and visualize for NLT 5 min.
Acceptance criteria: The principal spot from the Sample solution corresponds in R value to that from the Standard solution
3 ASSAY
3.1 Procedure
[Note-Solutions are stable for 4 days at room temperature when stored in amber glassware.]
Buffer: 0.02 M ammonium acetate. Dissolve 1.54 g of ammonium acetate in 1 L of water, and adjust with glacial acetic acid to a pH of 4.2 ± 0.1.
Solution A: Dissolve 1.71 g of sodium decanesulfonic acid in 1 L of methanol and Buffer mixture (33:67). Pass through a filter of 0.45-µm pore size.
Solution B: Dissolve 1.71 g of sodium decanesulfonic acid in 1 L of methanol and Buffer mixture (63:37). Pass through a filter of 0.45-µm pore size.
Mobile phase: See Table 1.
| Table 1 | ||
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 100 | 0 |
| 3.3 | 60 | 40 |
| 20 | 0 | 100 |
| 21 | 0 | 100 |
| 22 | 100 | 0 |
| 28 | 100 | 0 |
Diluent: Methanol and water (25:75)
Standard solution: 1.2 mg/mL of USP Codeine Sulfate RS in Diluent. Prepare by adding 70% of the flask volume of Diluent, and sonicate to dissolve. Dilute with Diluent to volume.
Sample solution: 1.2 mg/mL of codeine sulfate in Diluent, prepared by adding 70% of the flask volume of Diluent, then swirling, and letting it sit for 10 min. Dilute with Diluent to volume.
Chromatographic system
- (See Chromatography (621), System Suitability.)
- Mode: LC
- Detector: UV 280 nm
- Column: 4.6-mm × 15-cm; 3.5-µm packing L1
- Column temperature: 40 ± 2"
- Flow rate: 1.2 mL/min
- Injection volume: 30 µL
System suitability
- Sample: Standard solution
- Suitability requirements
- Tailing factor: NMT 2.0
- Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of codeine sulfate [(C18H21NO3)·H2SO4] in each mL of Oral Solution taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response from the Sample solution
rs= peak response from the Standard solution
Cs = concentration of USP Codeine Sulfate RS in the Standard solution (mg/mL)
Cu = nominal concentration of codeine sulfate in the Sample solution (mg/mL)
Acceptance criteria: 93.0%–105.0%
4 IMPURITIES
4.1 ORGANIC IMPURITIES
Buffer, Solution A, Solution B, Mobile phase, Diluent, Standard solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay.
Sensitivity solution: 0.6 µg/mL of USP Codeine Sulfate RS in Diluent from the Standard solution
System suitability
- Samples: Standard solution and Sensitivity solution
- Suitability requirements
- Relative standard deviation: NMT 2.0%, Standard solution
- Tailing factor: NMT 2.0, Standard solution
- Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each individual impurity in the portion of Oral Solution taken:
(ru/rs) × (Cs/Cu) × 100
ru = response of each individual impurity from the Sample solution
rs = response of codeine sulfate in the Standard solution
Cs = concentration of USP Codeine Sulfate RS in the Standard solution (mg/mL)
Cu = nominal concentration of codeine sulfate in the Sample solution (mg/mL)
Acceptance criteria
Individual impurities: See Table 2. Disregard any peak less than 0.05%.
| Table 2 | ||
| Related Compound | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Codeine-N-oxidea | 0.65 | 0.15 |
| Codeine | 1.00 | - |
| Codeinoneb | 1.16 | 0.15 |
| Individual unspecified degradant | - | 0.15 |
| Total impurities | - | 0.5 |
a 7,8-Didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol N-oxide.
b 7,8-Didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-one.
5 SPECIFIC TESTS
MICROBIAL ENUMERATION TESTS (61) and TESTS FOR SPECIFIED MICROORGANISMS (62): The total aerobic microbial count does not exceed 102 cfu/mL. The total yeasts and molds count does not exceed 20 cfu/mL. It meets the requirements of the test for absence of Escherichia coli.
PH (791): 2.8-3.8
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Store at controlled room temperature in a well-sealed container.
USP REFERENCE STANDARDS (11)
USP Codeine Sulfate RS

